JNJ Johnson and Johnson

Johnson & Johnson (JNJ) is currently at $150.45, up $0.85 or 0.57%

-- Would be highest close since May 18, 2020, when it closed at $150.52

-- Currently up seven consecutive days; up 5.68% over this period

-- Earlier Tuesday, at a hearing before a congressional subcommittee, representatives of five drug companies behind leading Covid-19 vaccine programs, including Johnson & Johnson, told lawmakers that they have confidence that one or more of their vaccines will work. But they warned of challenges ahead

-- On Monday, Johnson & Johnson announced that its board of directors has declared a cash dividend for the third quarter of 2020 of $1.01 per share on the company's common stock

-- Independent Research upgraded Johnson & Johnson to buy from hold and raised its price target to $164.00/share from $161.00/share, Benzinga reported

-- Longest winning streak since June 12, 2019, when it rose for eight straight trading days

-- Best seven day stretch since the seven days ending April 23, 2020, when it rose 6.49%

-- Up 6.98% month-to-date

-- Up 3.14% year-to-date

-- Down 3.25% from its all-time closing high of $155.51 on April 23, 2020

-- Up 16.77% from 52 weeks ago (July 23, 2019), when it closed at $128.84

-- Down 3.25% from its 52 week closing high of $155.51 on April 23, 2020

-- Up 35.37% from its 52 week closing low of $111.14 on March 23, 2020

-- Traded as high as $151.67; highest intraday level since May 18, 2020, when it hit $153.62

-- Up 1.38% at today's intraday high

All data as of 12:59:11 PM

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

July 21, 2020 13:26 ET (17:26 GMT)

Johnson and Johnson (NYSE:JNJ)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024

Johnson and Johnson (NYSE:JNJ)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024